NBIX Snapshot
Neurocrine Biosciences, Inc., a biopharmaceutical company, discovers, develops, and markets pharmaceutical products for the treatment of neurological, endocrine, and psychiatric diseases and disorders in the United States. The company is headquartered in San Diego, California.
Market Capitalization$8,236,801,000
Price to Sales6.82
Earnings per Share$0.7300
PE Ratio118.05
Most Recent Close$86.4900
52 Week High$108.02
52 Week Low$71.88
50-Day Moving Average$91.64
200-Day Moving Average$89.89
All data are from Alpha Vantage as of today. For more infomation on NBIX see Stock Dividend, Valuation, Price and Financial Data for Investors